Table 1.
Time after injury |
Groups | Drug delivery |
n (ELISA, WB) |
n (H,IHC) |
n (BBB) |
Total |
---|---|---|---|---|---|---|
24h | Sham + Vehicle | 1ul/hr for 24h | 4 | 3 | NA | 7 |
Sham + Tat-Bcl-xL | 10ug/day | 4 | − | NA | 4 | |
Injury + Vehicle | 5 | 3 | NA | 8 | ||
Injury + Tat-Bcl-xL | 5 | 3 | NA | 8 | ||
7days | Sham + Vehicle | 0.5ul/hr for 7 | 7 | 3 | NA | 10 |
Injury + Vehicle | days | 7 | 3 | NA | 10 | |
Injury + Tat-Bcl-xL | 5ug/day. | 7 | 3 | NA | 10 | |
Injury + Tat-BH4 | 7 | 3 | NA | 10 | ||
60 days | Sham + Vehicle | 0.5ul/hr for 7 | 3* | 3 | 10 | 10 |
Injury + Vehicle | days | 3* | 3 | 10 | 10 | |
Injury + Tat-Bcl-xL | 5ug/day. | 3* | 3 | 8# | 10 | |
Injury + Tat-BH4 | 3* | 3 | 10 | 10 | ||
TOTAL | 48 | 105 |
Only WB analysis but no Cell death ELISA was performed in this group.
An additional injury at the site of catheter implantation was observed at the time of perfusion in two Tat-Bcl-xL treated animals. Data from these animals were omitted from the analysis. n(ELISA, WB), number of animals for which apoptotic cell death was measured by ELISA and analysis of Bcl-xL levels were quantified by western blot. n(H, IHC), number of animals used for histology and immunohistochemistry analysis. n (BBB), number of animals for which BBB scores were obtained. NA, Not applicable